.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Cimetidine hydrochloride - Generic Drug Details

« Back to Dashboard
Cimetidine hydrochloride is the generic ingredient in four branded drugs marketed by Vintage Pharms Llc, Ani Pharms Inc, Hospira, Glaxosmithkline, Dava Pharms Inc, Cycle Pharms Ltd, Teva Parenteral, Luitpold, Pharm Assoc, Wockhardt, Apotex Inc, Hi Tech Pharma, and G And W Labs Inc, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for cimetidine hydrochloride. Two suppliers are listed for this compound.

Summary for Generic Name: cimetidine hydrochloride

Tradenames:4
Patents:0
Applicants:13
NDAs:24
Drug Master File Entries: see list25
Suppliers / Packaging: see list2
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: cimetidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
TAGAMET
cimetidine hydrochloride
SOLUTION;ORAL017924-001Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
Hospira
CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cimetidine hydrochloride
INJECTABLE;INJECTION074468-003Dec 29, 1994DISCNNo► subscribe► subscribe
Ani Pharms Inc
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
SOLUTION;ORAL074610-001Sep 26, 1996RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cimetidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
TAGAMET
cimetidine hydrochloride
SOLUTION;ORAL017924-001Approved Prior to Jan 1, 19823,950,333► subscribe
Glaxosmithkline
TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cimetidine hydrochloride
INJECTABLE;INJECTION019434-001Oct 31, 19853,950,333► subscribe
Glaxosmithkline
TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cimetidine hydrochloride
INJECTABLE;INJECTION019434-001Oct 31, 19853,950,933► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc